Form D — Halia Therapeutics, Inc.
0001829255-26-000001 · filed Aug 31, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $20,000,000
- Total sold
- $3,486,474
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Halia Therapeutics, Inc.
- CIK
- 1829255
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3900 N. Traverse Mountain Blvd.
Lehi, UT 84043 - Phone
- 801-842-1652
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jeffrey Burton · Executive OfficerLehi, UT Find on LinkedIn ↗
-
David Bearss · DirectorLehi, UT Find on LinkedIn ↗
-
David Checketts · DirectorLehi, UT Find on LinkedIn ↗
-
John S.K. Kauwe · DirectorLehi, UT Find on LinkedIn ↗
-
Gary B. Sabin · DirectorLehi, UT Find on LinkedIn ↗
-
Mary Beckerle · DirectorLehi, UT Find on LinkedIn ↗
-
Preston Campbell · DirectorLehi, UT Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗